Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis

Published:2017-09-30 Issue:3 Volume:36 Page:274-281
ISSN:2211-9140
Container-title:Kidney Research and Clinical Practice
language:en
Short-container-title:Kidney Res Clin Pract.

Author:

Kim Sollip¹,Kim Hyun-Jung²,Ahn Hyeong-Sik²,Oh Se Won³,Han Kum Hyun³,Um Tae-Hyun¹,Cho Chong-Rae¹,Han Sang Youb³

Affiliation:

1. Department of Laboratory Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea

2. Department of Preventive Medicine, Korea University College of Medicine, Seoul, Korea

3. Department of Internal Medicine, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea

Publisher

The Korean Society of Nephrology

Subject

Urology,Nephrology

Link

http://pdf.medrang.co.kr/KRCP2/2017/036/KRCP036-03-09.pdf

Reference29 articles.

1. Serum Uric Acid and Progression of Kidney Disease: A Longitudinal Analysis and Mini-Review

2. Uric Acid and Cardiovascular Risk

3. Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?

4. Uric Acid and Incident Kidney Disease in the Community

5. Elevated Uric Acid Increases the Risk for Kidney Disease

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Allopurinol on Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis;The Journal of Pediatric Pharmacology and Therapeutics;2024-08-01

2. A Possible Therapeutic Application of the Selective Inhibitor of Urate Transporter 1, Dotinurad, for Metabolic Syndrome, Chronic Kidney Disease, and Cardiovascular Disease;Cells;2024-03-04

3. Combination Treatment with Verinurad and Allopurinol in CKD;Journal of the American Society of Nephrology;2024-02-20

4. Effectiveness and safety of different doses of febuxostat compared with allopurinol in the treatment of hyperuricemia: a meta-analysis of randomized controlled trials;BMC Pharmacology and Toxicology;2023-12-14

5. Celebrating Versatility: Febuxostat’s Multifaceted Therapeutic Application;Life;2023-11-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3